Uricaemia as a surrogate endpoint in gout trials and the treat-to-target approach for gout management

被引：1

作者：

Bardin, Thomas ^{[1
,2
]}

Richette, Pascal ^{[3
,4
]}

机构：

[1] Univ Paris, INSERM, U1132, F-75010 Paris, France

[2] Inst Mutualiste Montsouris, Dept Med, Paris, France

[3] Hop Lariboisiere, APHP Paris Nord, Dept Rheumatol, Paris, France

[4] Univ Paris, INSERM, U1132, Paris, France

来源：

LANCET RHEUMATOLOGY | 2022年 / 4卷 / 01期

关键词：

D O I：

10.1016/S2665-9913(21)00358-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E7 / E8

页数：2

共 7 条

[1] Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) [J].

Dalbeth, Nicola ;

Bardin, Thomas ;

Doherty, Michael ;

Liote, Frederic ;

Richette, Pascal ;

Saag, Kenneth G. ;

So, Alexander K. ;

Stamp, Lisa K. ;

Choi, Hyon K. ;

Terkeltaub, Robert .

NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (09) :561-568

[2] 2020 American College of Rheumatology Guideline for the Management of Gout [J].

FitzGerald, John D. ;

Dalbeth, Nicola ;

Mikuls, Ted ;

Brignardello-Petersen, Romina ;

Guyatt, Gordon ;

Abeles, A. M. ;

Gelber, Allan C. ;

Harrold, Leslie R. ;

Khanna, Dinesh ;

King, Charles ;

Levy, Gerald ;

Libbey, Caryn ;

Mount, David ;

Pillinger, Michael H. ;

Rosenthal, Ann ;

Singh, Jasvinder A. ;

Sims, James Edward ;

Smith, Benjamin J. ;

Wenger, Neil S. ;

Sharon, Sangmee ;

Danve, Abhijeet ;

Khanna, Puja P. ;

Kim, Seoyoung C. ;

Lenert, Aleksander ;

Poon, Samuel ;

Qasim, Anila ;

Sehra, Shiv T. ;

Sharma, Tarun Sudhir Kumar ;

Toprover, Michael ;

Turgunbaev, Marat ;

Zeng, Linan ;

Zhang, Mary Ann ;

Turner, Amy S. ;

Neogi, Tuhina .

ARTHRITIS CARE & RESEARCH, 2020, 72 (06) :744-760

[3] Gout-associated uric acid crystals activate the NALP3 inflammasome [J].

Martinon, F ;

Pétrilli, V ;

Mayor, A ;

Tardivel, A ;

Tschopp, J .

NATURE, 2006, 440 (7081) :237-241

[4] 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy [J].

Pascart, Tristan ;

Latourte, Augustin ;

Flipo, Rene-Marc ;

Chales, Gerard ;

Coblentz-Baumann, Laurence ;

Cohen-Solal, Alain ;

Ea, Hang-Korng ;

Grichy, Jacques ;

Letayernier, Emmanuel ;

Liote, Frederic ;

Ottaviani, Sebastien ;

Sigwalt, Pierre ;

Vandecandelaere, Guy ;

Richette, Pascal ;

Bardin, Thomas .

JOINT BONE SPINE, 2020, 87 (05) :395-404

[5] Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout [J].

Perez-Ruiz, F ;

Calabozo, M ;

Pijoan, J ;

Herrero-Beites, AM ;

Ruibal, A .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (04) :356-360

[6]

Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]

[7] Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials [J].

Stamp, Lisa K. ;

Frampton, Christopher ;

Morillon, Melanie B. ;

Taylor, William J. ;

Dalbeth, Nicola ;

Singh, Jasvinder A. ;

Doherty, Michael ;

Zhang, Weiya ;

Richardson, Helen ;

Sarmanova, Aye ;

Christensen, Robin .

LANCET RHEUMATOLOGY, 2022, 4 (01) :E53-E60

← 1 →